{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T21:51:33Z","timestamp":1787003493846,"version":"build-2736575974"},"reference-count":48,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2025,5,27]],"date-time":"2025-05-27T00:00:00Z","timestamp":1748304000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,5,27]],"date-time":"2025-05-27T00:00:00Z","timestamp":1748304000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/100000002","name":"U.S. Department of Health & Human Services | National Institutes of Health","doi-asserted-by":"publisher","award":["R01AI099108"],"award-info":[{"award-number":["R01AI099108"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"U.S. Department of Health & Human Services | National Institutes of Health","doi-asserted-by":"publisher","award":["R01AI129945"],"award-info":[{"award-number":["R01AI129945"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"U.S. Department of Health & Human Services | National Institutes of Health","doi-asserted-by":"publisher","award":["R01AI157155"],"award-info":[{"award-number":["R01AI157155"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"U.S. Department of Health & Human Services | National Institutes of Health","doi-asserted-by":"publisher","award":["75N93021C00015"],"award-info":[{"award-number":["75N93021C00015"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000030","name":"U.S. Department of Health & Human Services | Centers for Disease Control and Prevention","doi-asserted-by":"publisher","award":["75D30120C08379"],"award-info":[{"award-number":["75D30120C08379"]}],"id":[{"id":"10.13039\/100000030","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000030","name":"U.S. Department of Health & Human Services | Centers for Disease Control and Prevention","doi-asserted-by":"publisher","award":["75D30120C08150"],"award-info":[{"award-number":["75D30120C08150"]}],"id":[{"id":"10.13039\/100000030","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Immunol"],"published-print":{"date-parts":[[2025,6]]},"DOI":"10.1038\/s41590-025-02162-2","type":"journal-article","created":{"date-parts":[[2025,5,27]],"date-time":"2025-05-27T05:04:38Z","timestamp":1748322278000},"page":"829-836","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Intrinsic immunogenicity is a major determinant of type-specific responses in SARS-CoV-2 infections"],"prefix":"10.1038","volume":"26","author":[{"ORCID":"https:\/\/orcid.org\/0009-0006-3327-1511","authenticated-orcid":false,"given":"Grace E.","family":"Quirk","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marta V.","family":"Schoenle","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kameron L.","family":"Peyton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jennifer L.","family":"Uhrlaub","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Branden","family":"Lau","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4624-7212","authenticated-orcid":false,"given":"Chieh-Yu","family":"Liang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2362-9509","authenticated-orcid":false,"given":"Jefferey L.","family":"Burgess","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katherine","family":"Ellingson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shawn","family":"Beitel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James","family":"Romine","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3480-849X","authenticated-orcid":false,"given":"Karen","family":"Lutrick","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ashley","family":"Fowlkes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amadea","family":"Britton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Harmony L.","family":"Tyner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5960-1308","authenticated-orcid":false,"given":"Alberto J.","family":"Caban-Martinez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Allison","family":"Naleway","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3952-9230","authenticated-orcid":false,"given":"Manjusha","family":"Gaglani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarang","family":"Yoon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura J.","family":"Edwards","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4503-9745","authenticated-orcid":false,"given":"Lauren","family":"Olsho","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Dake","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Riccardo","family":"Valdez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9352-7877","authenticated-orcid":false,"given":"Aubree","family":"Gordon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8791-3165","authenticated-orcid":false,"given":"Michael S.","family":"Diamond","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4939-9337","authenticated-orcid":false,"given":"Bonnie J.","family":"LaFleur","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Janko \u017d.","family":"Nikolich","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ryan","family":"Sprissler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Worobey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8377-7699","authenticated-orcid":false,"given":"Deepta","family":"Bhattacharya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,5,27]]},"reference":[{"key":"2162_CR1","doi-asserted-by":"publisher","unstructured":"Amanat, F. et al. SARS-CoV-2 mRNA vaccination induces functionally diverse antibodies to NTD, RBD and S2. Cell https:\/\/doi.org\/10.1016\/j.cell.2021.06.005 (2021).","DOI":"10.1016\/j.cell.2021.06.005"},{"key":"2162_CR2","doi-asserted-by":"publisher","first-page":"1201","DOI":"10.1016\/j.cell.2021.01.050","volume":"184","author":"A Sokal","year":"2021","unstructured":"Sokal, A. et al. Maturation and persistence of the anti-SARS-CoV-2 memory B cell response. Cell 184, 1201\u20131213.e14 (2021).","journal-title":"Cell"},{"key":"2162_CR3","doi-asserted-by":"publisher","first-page":"592","DOI":"10.1038\/s41586-023-06025-4","volume":"617","author":"WB Alsoussi","year":"2023","unstructured":"Alsoussi, W. B. et al. SARS-CoV-2 Omicron boosting induces de novo B cell response in humans. Nature 617, 592\u2013598 (2023).","journal-title":"Nature"},{"key":"2162_CR4","doi-asserted-by":"publisher","first-page":"e20220367","DOI":"10.1084\/jem.20220367","volume":"219","author":"M Agudelo","year":"2022","unstructured":"Agudelo, M. et al. Plasma and memory antibody responses to Gamma SARS-CoV-2 provide limited cross-protection to other variants. J. Exp. Med. 219, e20220367 (2022).","journal-title":"J. Exp. Med."},{"key":"2162_CR5","doi-asserted-by":"publisher","first-page":"1093","DOI":"10.1016\/j.chom.2022.04.014","volume":"30","author":"JP Evans","year":"2022","unstructured":"Evans, J. P. et al. Neutralization of SARS-CoV-2 Omicron sub-lineages BA.1, BA.1.1, and BA.2. Cell Host Microbe 30, 1093\u20131102.e3 (2022).","journal-title":"Cell Host Microbe"},{"key":"2162_CR6","doi-asserted-by":"publisher","DOI":"10.1126\/sciimmunol.abq2427","volume":"7","author":"J Quandt","year":"2022","unstructured":"Quandt, J. et al. Omicron BA.1 breakthrough infection drives cross-variant neutralization and memory B cell formation against conserved epitopes. Sci. Immunol. 7, eabq2427 (2022).","journal-title":"Sci. Immunol."},{"key":"2162_CR7","doi-asserted-by":"publisher","DOI":"10.1126\/sciimmunol.abq3511","volume":"7","author":"CI Kaku","year":"2022","unstructured":"Kaku, C. I. et al. Recall of preexisting cross-reactive B cell memory after Omicron BA.1 breakthrough infection. Sci. Immunol. 7, eabq3511 (2022).","journal-title":"Sci. Immunol."},{"key":"2162_CR8","doi-asserted-by":"publisher","first-page":"619","DOI":"10.1126\/science.adc9127","volume":"378","author":"Y-J Park","year":"2022","unstructured":"Park, Y.-J. et al. Imprinted antibody responses against SARS-CoV-2 Omicron sublineages. Science 378, 619\u2013627 (2022).","journal-title":"Science"},{"key":"2162_CR9","doi-asserted-by":"publisher","first-page":"1025","DOI":"10.1016\/j.cell.2022.01.018","volume":"185","author":"K R\u00f6ltgen","year":"2022","unstructured":"R\u00f6ltgen, K. et al. Immune imprinting, breadth of variant recognition, and germinal center response in human SARS-CoV-2 infection and vaccination. Cell 185, 1025\u20131040.e14 (2022).","journal-title":"Cell"},{"key":"2162_CR10","doi-asserted-by":"publisher","first-page":"904","DOI":"10.1016\/j.immuni.2024.02.016","volume":"57","author":"MA Tortorici","year":"2024","unstructured":"Tortorici, M. A. et al. Persistent immune imprinting occurs after vaccination with the COVID-19 XBB.1.5 mRNA booster in humans. Immunity 57, 904\u2013911.e4 (2024).","journal-title":"Immunity"},{"key":"2162_CR11","doi-asserted-by":"crossref","unstructured":"Liang, C.-Y. et al. Imprinting of serum neutralizing antibodies by Wuhan-1 mRNA vaccines. Nature 630, 950\u2013960 (2024).","DOI":"10.1038\/s41586-024-07539-1"},{"key":"2162_CR12","doi-asserted-by":"publisher","first-page":"111496","DOI":"10.1016\/j.celrep.2022.111496","volume":"41","author":"EM Anderson","year":"2022","unstructured":"Anderson, E. M. et al. SARS-CoV-2 infections elicit higher levels of original antigenic sin antibodies compared with SARS-CoV-2 mRNA vaccinations. Cell Rep. 41, 111496 (2022).","journal-title":"Cell Rep."},{"key":"2162_CR13","first-page":"572","volume":"104","author":"T Francis","year":"1960","unstructured":"Francis, T. On the doctrine of original antigenic sin. Proc. Am. Philos. Soc. 104, 572\u2013578 (1960).","journal-title":"Proc. Am. Philos. Soc."},{"key":"2162_CR14","doi-asserted-by":"crossref","unstructured":"Cobey, S. Vaccination against rapidly evolving pathogens and the entanglements of memory. Nat. Immunol. 25, 2015\u20132023 (2024).","DOI":"10.1038\/s41590-024-01970-2"},{"key":"2162_CR15","doi-asserted-by":"publisher","first-page":"909","DOI":"10.1016\/j.immuni.2023.04.012","volume":"56","author":"M Koutsakos","year":"2023","unstructured":"Koutsakos, M. & Ellebedy, A. H. Immunological imprinting: understanding COVID-19. Immunity 56, 909\u2013913 (2023).","journal-title":"Immunity"},{"key":"2162_CR16","doi-asserted-by":"publisher","first-page":"2434","DOI":"10.1016\/j.cell.2022.05.022","volume":"185","author":"Z Zhang","year":"2022","unstructured":"Zhang, Z. et al. Humoral and cellular immune memory to four COVID-19 vaccines. Cell 185, 2434\u20132451.e17 (2022).","journal-title":"Cell"},{"key":"2162_CR17","doi-asserted-by":"publisher","first-page":"eabi6950","DOI":"10.1126\/sciimmunol.abi6950","volume":"6","author":"RR Goel","year":"2021","unstructured":"Goel, R. R. et al. Distinct antibody and memory B cell responses in SARS-CoV-2 na\u00efve and recovered individuals following mRNA vaccination. Sci. Immunol. 6, eabi6950 (2021).","journal-title":"Sci. Immunol."},{"key":"2162_CR18","doi-asserted-by":"publisher","first-page":"925","DOI":"10.1016\/j.immuni.2020.10.004","volume":"53","author":"TJ Ripperger","year":"2020","unstructured":"Ripperger, T. J. et al. Orthogonal SARS-CoV-2 serological assays enable surveillance of low-prevalence communities and reveal durable humoral immunity. Immunity 53, 925\u2013933.e4 (2020).","journal-title":"Immunity"},{"key":"2162_CR19","doi-asserted-by":"publisher","first-page":"1024","DOI":"10.1016\/j.cell.2020.09.037","volume":"183","author":"L Piccoli","year":"2020","unstructured":"Piccoli, L. et al. Mapping neutralizing and immunodominant sites on the SARS-CoV-2 spike receptor-binding domain by structure-guided high-resolution serology. Cell 183, 1024\u20131042.e21 (2020).","journal-title":"Cell"},{"key":"2162_CR20","doi-asserted-by":"publisher","first-page":"1295","DOI":"10.1016\/j.cell.2020.08.012","volume":"182","author":"TN Starr","year":"2020","unstructured":"Starr, T. N. et al. Deep mutational scanning of SARS-CoV-2 receptor binding domain reveals constraints on folding and ACE2 binding. Cell 182, 1295\u20131310.e20 (2020).","journal-title":"Cell"},{"key":"2162_CR21","doi-asserted-by":"publisher","unstructured":"Motozono, C. et al. SARS-CoV-2 spike L452R variant evades cellular immunity and increases infectivity. Cell Host Microbe https:\/\/doi.org\/10.1016\/j.chom.2021.06.006 (2021).","DOI":"10.1016\/j.chom.2021.06.006"},{"key":"2162_CR22","doi-asserted-by":"publisher","first-page":"463","DOI":"10.1016\/j.chom.2021.02.003","volume":"29","author":"AJ Greaney","year":"2021","unstructured":"Greaney, A. J. et al. Comprehensive mapping of mutations in the SARS-CoV-2 receptor-binding domain that affect recognition by polyclonal human plasma antibodies. Cell Host Microbe 29, 463\u2013476.e6 (2021).","journal-title":"Cell Host Microbe"},{"key":"2162_CR23","doi-asserted-by":"publisher","unstructured":"He, P. et al. SARS-CoV-2 Delta and Omicron variants evade population antibody response by mutations in a single spike epitope. Nat. Microbiol. https:\/\/doi.org\/10.1038\/s41564-022-01235-4 (2022).","DOI":"10.1038\/s41564-022-01235-4"},{"key":"2162_CR24","doi-asserted-by":"publisher","DOI":"10.1128\/JCM.00921-21","volume":"59","author":"V Tchesnokova","year":"2021","unstructured":"Tchesnokova, V. et al. Acquisition of the L452R mutation in the ACE2-binding interface of spike protein triggers recent massive expansion of SARS-CoV-2 variants. J. Clin. Microbiol. 59, e0092121 (2021).","journal-title":"J. Clin. Microbiol."},{"key":"2162_CR25","doi-asserted-by":"publisher","DOI":"10.1371\/journal.ppat.1010248","volume":"18","author":"AJ Greaney","year":"2021","unstructured":"Greaney, A. J. et al. A SARS-CoV-2 variant elicits an antibody response with a shifted immunodominance hierarchy. PLoS Pathog. 18, e1010248 (2021).","journal-title":"PLoS Pathog."},{"key":"2162_CR26","doi-asserted-by":"publisher","first-page":"2332","DOI":"10.1016\/j.cell.2021.03.028","volume":"184","author":"M McCallum","year":"2021","unstructured":"McCallum, M. et al. N-terminal domain antigenic mapping reveals a site of vulnerability for SARS-CoV-2. Cell 184, 2332\u20132347.e16 (2021).","journal-title":"Cell"},{"key":"2162_CR27","doi-asserted-by":"publisher","first-page":"819","DOI":"10.1016\/j.chom.2021.03.005","volume":"29","author":"G Cerutti","year":"2021","unstructured":"Cerutti, G. et al. Potent SARS-CoV-2 neutralizing antibodies directed against spike N-terminal domain target a single supersite. Cell Host Microbe 29, 819\u2013833.e7 (2021).","journal-title":"Cell Host Microbe"},{"key":"2162_CR28","doi-asserted-by":"publisher","first-page":"2316","DOI":"10.1016\/j.cell.2021.03.029","volume":"184","author":"N Suryadevara","year":"2021","unstructured":"Suryadevara, N. et al. Neutralizing and protective human monoclonal antibodies recognizing the N-terminal domain of the SARS-CoV-2 spike protein. Cell 184, 2316\u20132331.e15 (2021).","journal-title":"Cell"},{"key":"2162_CR29","doi-asserted-by":"crossref","unstructured":"Shroff, R. T. et al. Immune responses to two and three doses of the BNT162b2 mRNA vaccine in adults with solid tumors. Nat. Med. 27, 2002\u20132011 (2021).","DOI":"10.1038\/s41591-021-01542-z"},{"key":"2162_CR30","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1038\/s41577-022-00784-3","volume":"23","author":"Y Chen","year":"2023","unstructured":"Chen, Y. et al. Broadly neutralizing antibodies to SARS-CoV-2 and other human coronaviruses. Nat. Rev. Immunol. 23, 189\u2013199 (2023).","journal-title":"Nat. Rev. Immunol."},{"key":"2162_CR31","doi-asserted-by":"publisher","first-page":"906","DOI":"10.1007\/s10875-021-00997-6","volume":"41","author":"J Hicks","year":"2021","unstructured":"Hicks, J. et al. Serologic cross-reactivity of SARS-CoV-2 with endemic and seasonal betacoronaviruses. J. Clin. Immunol. 41, 906\u2013913 (2021).","journal-title":"J. Clin. Immunol."},{"key":"2162_CR32","doi-asserted-by":"publisher","unstructured":"Schiepers, A. et al. Molecular fate-mapping of serum antibody responses to repeat immunization. Nature https:\/\/doi.org\/10.1038\/s41586-023-05715-3 (2023).","DOI":"10.1038\/s41586-023-05715-3"},{"key":"2162_CR33","doi-asserted-by":"publisher","first-page":"5554","DOI":"10.1016\/j.cell.2024.07.052","volume":"187","author":"AA Cohen","year":"2024","unstructured":"Cohen, A. A. et al. Mosaic sarbecovirus nanoparticles elicit cross-reactive responses in pre-vaccinated animals. Cell 187, 5554\u20135571.e19 (2024).","journal-title":"Cell"},{"key":"2162_CR34","doi-asserted-by":"publisher","DOI":"10.2196\/28925","volume":"10","author":"K Lutrick","year":"2021","unstructured":"Lutrick, K. et al. COVID-19 infection, reinfection, and vaccine effectiveness in a prospective cohort of Arizona frontline\/essential workers: the AZ HEROES research protocol. JMIR Res. Protoc. 10, e28925 (2021).","journal-title":"JMIR Res. Protoc."},{"key":"2162_CR35","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0286297","volume":"18","author":"LI Horwitz","year":"2023","unstructured":"Horwitz, L. I. et al. Researching COVID to Enhance Recovery (RECOVER) adult study protocol: rationale, objectives, and design. PLoS ONE 18, e0286297 (2023).","journal-title":"PLoS ONE"},{"key":"2162_CR36","doi-asserted-by":"publisher","first-page":"167058","DOI":"10.1016\/j.jmb.2021.167058","volume":"433","author":"C Laffeber","year":"2021","unstructured":"Laffeber, C., de Koning, K., Kanaar, R. & Lebbink, J. H. G. Experimental evidence for enhanced receptor binding by rapidly spreading SARS-CoV-2 variants. J. Mol. Biol. 433, 167058 (2021).","journal-title":"J. Mol. Biol."},{"key":"2162_CR37","doi-asserted-by":"publisher","first-page":"640","DOI":"10.1038\/s41586-022-04690-5","volume":"605","author":"MM DeGrace","year":"2022","unstructured":"DeGrace, M. M. et al. Defining the risk of SARS-CoV-2 variants on immune protection. Nature 605, 640\u2013652 (2022).","journal-title":"Nature"},{"key":"2162_CR38","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-024-47451-w","volume":"15","author":"J Pu\u0161nik","year":"2024","unstructured":"Pu\u0161nik, J. et al. Vaccination impairs de novo immune response to omicron breakthrough infection, a precondition for the original antigenic sin. Nat. Commun. 15, 3102 (2024).","journal-title":"Nat. Commun."},{"key":"2162_CR39","doi-asserted-by":"publisher","first-page":"622","DOI":"10.1038\/s41590-024-01776-2","volume":"25","author":"X He","year":"2024","unstructured":"He, X. et al. The receptor binding domain of SARS-CoV-2 Omicron subvariants targets Siglec-9 to decrease its immunogenicity by preventing macrophage phagocytosis. Nat. Immunol. 25, 622\u2013632 (2024).","journal-title":"Nat. Immunol."},{"key":"2162_CR40","doi-asserted-by":"publisher","first-page":"3235","DOI":"10.1038\/s41467-023-38867-x","volume":"14","author":"AS Gonzalez-Reiche","year":"2023","unstructured":"Gonzalez-Reiche, A. S. et al. Sequential intrahost evolution and onward transmission of SARS-CoV-2 variants. Nat. Commun. 14, 3235 (2023).","journal-title":"Nat. Commun."},{"key":"2162_CR41","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1038\/s41586-023-06753-7","volume":"625","author":"A Yisimayi","year":"2024","unstructured":"Yisimayi, A. et al. Repeated Omicron exposures override ancestral SARS-CoV-2 immune imprinting. Nature 625, 148\u2013156 (2024).","journal-title":"Nature"},{"key":"2162_CR42","doi-asserted-by":"publisher","first-page":"110561","DOI":"10.1016\/j.celrep.2022.110561","volume":"38","author":"BM Hauser","year":"2022","unstructured":"Hauser, B. M. et al. Rationally designed immunogens enable immune focusing following SARS-CoV-2 spike imprinting. Cell Rep. 38, 110561 (2022).","journal-title":"Cell Rep."},{"key":"2162_CR43","doi-asserted-by":"publisher","unstructured":"Dvorscek, A. R. et al. Conversion of vaccines from low to high immunogenicity by antibodies with epitope complementarity. Immunity https:\/\/doi.org\/10.1016\/j.immuni.2024.08.017 (2024).","DOI":"10.1016\/j.immuni.2024.08.017"},{"key":"2162_CR44","doi-asserted-by":"publisher","first-page":"573","DOI":"10.1016\/j.cels.2020.09.005","volume":"11","author":"A Amitai","year":"2020","unstructured":"Amitai, A. et al. Defining and manipulating B cell immunodominance hierarchies to elicit broadly neutralizing antibody responses against influenza virus. Cell Syst. 11, 573\u2013588.e9 (2020).","journal-title":"Cell Syst."},{"key":"2162_CR45","doi-asserted-by":"publisher","first-page":"17957","DOI":"10.1073\/pnas.1906613117","volume":"117","author":"AH Ellebedy","year":"2020","unstructured":"Ellebedy, A. H. et al. Adjuvanted H5N1 influenza vaccine enhances both cross-reactive memory B cell and strain-specific naive B cell responses in humans. Proc. Natl Acad. Sci. USA 117, 17957\u201317964 (2020).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"2162_CR46","doi-asserted-by":"publisher","first-page":"e31574","DOI":"10.2196\/31574","volume":"10","author":"LJ Edwards","year":"2021","unstructured":"Edwards, L. J. et al. Research on the epidemiology of SARS-CoV-2 in essential response personnel (RECOVER): protocol for a multisite longitudinal cohort study. JMIR Res. Protoc. 10, e31574 (2021).","journal-title":"JMIR Res. Protoc."},{"key":"2162_CR47","doi-asserted-by":"publisher","unstructured":"Goldfarb, D. M. et al. Self-collected saline gargle samples as an alternative to healthcare worker collected nasopharyngeal swabs for COVID-19 diagnosis in outpatients. J. Clin. Microbiol. https:\/\/doi.org\/10.1101\/2020.09.13.20188334 (2020).","DOI":"10.1101\/2020.09.13.20188334"},{"key":"2162_CR48","doi-asserted-by":"publisher","first-page":"1403","DOI":"10.1038\/s41564-020-0770-5","volume":"5","author":"A Rambaut","year":"2020","unstructured":"Rambaut, A. et al. A dynamic nomenclature proposal for SARS-CoV-2 lineages to assist genomic epidemiology. Nat. Microbiol. 5, 1403\u20131407 (2020).","journal-title":"Nat. Microbiol."}],"container-title":["Nature Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41590-025-02162-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41590-025-02162-2","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41590-025-02162-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,3]],"date-time":"2025-06-03T16:28:33Z","timestamp":1748968113000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41590-025-02162-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5,27]]},"references-count":48,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2025,6]]}},"alternative-id":["2162"],"URL":"https:\/\/doi.org\/10.1038\/s41590-025-02162-2","relation":{"has-preprint":[{"id-type":"doi","id":"10.1101\/2023.09.12.23295384","asserted-by":"object"}]},"ISSN":["1529-2908","1529-2916"],"issn-type":[{"value":"1529-2908","type":"print"},{"value":"1529-2916","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,5,27]]},"assertion":[{"value":"23 October 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 April 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 May 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Sana Biotechnology has licensed intellectual property of D.B. and Washington University in St. Louis. Jasper Therapeutics and Inograft Therapeutics have licensed intellectual property of D.B. and Stanford University. D.B. served on an advisory panel for GlaxoSmithKline on COVID-19 therapeutic antibodies. D.B. serves on the scientific advisory board for Hillevax. D.B. is a scientific cofounder of Aleutian Therapeutics. B.J.L. has a financial interest in Cofactor Genomics, Inc. and Iron Horse Dx. Geneticure Inc. has licensed intellectual property of R.S. and R.S. is a cofounder of Geneticure Inc. M.W. has received consulting fees from Gerson Lehrman Group regarding SARS-CoV-2 and the COVID-19 pandemic. M.S.D. is a consultant or advisor for Inbios, Vir Biotechnology, IntegerBio, Moderna, Merck and GlaxoSmithKline. The Diamond laboratory has received unrelated funding support in sponsored research agreements from Vir Biotechnology, Emergent BioSolutions and IntegerBio. The other authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}